
News Center
Category: Uncategorized
Home Company News Center Uncategorized
July 28, 2023
PGx testing informs clinical management for cancer patients
- By Variantyx
- Posted in Uncategorized
Somatic testing of solid tumors has become the standard of care. Specific mutations in genes such as BRAF, EGFR, NTRK...
July 7, 2023
Company Spotlight Series: Greice Krautz-Peterson
- By Variantyx
- Posted in Uncategorized
Meet Greice, Associate Director of Germline Assay Development at Variantyx! This inspired me to get an MS and PhD in...
July 5, 2023
Variantyx updates secondary findings reporting policy to ACMG v3.2
- By Variantyx
- Posted in Uncategorized
Just 13 days ago, June 22nd to be exact, the American College of Medical Genetics and Genomics (ACMG) published the...
May 25, 2022
Spotlight on inherited ataxias
- By Variantyx, Inc
- Posted in Uncategorized
In its most basic form, ataxia is a neurological symptom. It’s defined specifically as a lack of muscle control or...
May 25, 2022
Spotlight on Fragile X syndrome
- By Variantyx, Inc
- Posted in Uncategorized
Fragile X syndrome (FXS) is one of the most common heritable forms of intellectual disability, occurring in approximately 1 in...
January 26, 2021
Variantyx Launches Its WGS-Based Prenatal Test for High-Risk Pregnancies, Enters Women’s Health Market
- By Variantyx
- Posted in Uncategorized
January 26, 2021 Variantyx, a leader in high complexity hereditary disease testing, announced today that it will launch its Genomic Unity®...
September 9, 2019
Cancer predisposition variants: looking beyond BRCA1/2
- By Variantyx, Inc
- Posted in Clinical Education
Everyone has some risk of developing cancer. In fact, nearly 40% of people will be diagnosed with cancer at some...